Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01798 |
| Species: | Homo sapiens |
| Position : | chr7:55019000-55092000 |
| Year: | 2025 |
| Title: | ALDH1A3 promotes aggressive basal-like pancreatic cancer through an AP-1/RUNX2 enhancer network |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 40781158 |
| MONDO: | |
| Tissue: | Hypothalamus |
| Tissue Ontology ID: | UBERON:0001898 |
| Cell Source: | Primary rat hypothalamic cells |
| CVCL ID: | |
| Cell Type: | rat hypothalamic cell |
| Cell Ontology ID: | CL:0000540 |
| Experiment Type: | TF binding assay, Enhancer activity assay |
| High Throughput Method: | CUT&Tag, RNA-seq |
| Low Throughput Method: | RT-RT-qPCR, Western blot |
| Target gene : | EGFR |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_01536 | chr7:54978916-55304142 | Breast | breast carcinoma cell | breast carcinoma |